{"id":2705,"date":"2022-06-30T05:30:00","date_gmt":"2022-06-30T05:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/"},"modified":"2022-06-30T05:30:00","modified_gmt":"2022-06-30T05:30:00","slug":"change-in-number-of-shares-and-votes-in-xvivo-perfusion","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/","title":{"rendered":"Change in number of shares and votes in XVIVO Perfusion"},"content":{"rendered":"<div class=\"mfn-body\">\n<p>The number of shares and votes in XVIVO Perfusion AB (publ) has during June 2022 increased by 63,301 shares and votes as a result of warrants being exercised as part of the company\u2019s 2020 incentive program. As of June 30, 2022 there are thus in total\u00a029,561,967\u00a0shares and votes in the company.<\/p>\n<p>June 30, 2022<br \/>Gothenburg<br \/>XVIVO Perfusion AB (publ)<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-fb9cf3b124f9\">\n<p><strong class=\"mfn-heading-1\">For further information, please contact:<\/strong><\/p>\n<hr\/>\n<p>Dag Andersson, CEO, +46 76 643 30 31, e-mail:\u00a0dag.andersson@xvivogroup.com<br \/>Kristoffer\u00a0Nordstr\u00f6m, CFO, +46 73 519 21 64, e-mail:\u00a0kristoffer.nordstrom@xvivogroup.com<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-da5f5ee9f867\">\n<p><strong class=\"mfn-heading-1\">About Us<\/strong><\/p>\n<hr\/>\n<p>Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs &#8211; so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com\/us.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-regulatory mfn-regulatory-lhfi\">\n<p><em>This information is information that XVIVO Perfusion AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2022-06-30 07:30 CEST.<\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Attachments<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/storage.mfn.se\/df274d22-0628-462c-b9b4-a3ed9c1a451a\/change-in-number-of-shares-and-votes-in-xvivo-perfusion.pdf\" class=\"mfn-generated mfn-primary\" target=\"_blank\" rel=\"nofollow noopener\">Change in number of shares and votes in XVIVO Perfusion<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The number of shares and votes in XVIVO Perfusion AB (publ) has during June 2022 increased by 63,301 shares and&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2705","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-lhfi","mfn-news-tag-mfn-ca","mfn-news-tag-mfn-ca-shares","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Change in number of shares and votes in XVIVO Perfusion - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Change in number of shares and votes in XVIVO Perfusion - XVIVO\" \/>\n<meta property=\"og:description\" content=\"The number of shares and votes in XVIVO Perfusion AB (publ) has during June 2022 increased by 63,301 shares and...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\\\/\",\"name\":\"Change in number of shares and votes in XVIVO Perfusion - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2022-06-30T05:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Change in number of shares and votes in XVIVO Perfusion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Change in number of shares and votes in XVIVO Perfusion - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/","og_locale":"en_US","og_type":"article","og_title":"Change in number of shares and votes in XVIVO Perfusion - XVIVO","og_description":"The number of shares and votes in XVIVO Perfusion AB (publ) has during June 2022 increased by 63,301 shares and...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/","name":"Change in number of shares and votes in XVIVO Perfusion - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2022-06-30T05:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/change-in-number-of-shares-and-votes-in-xvivo-perfusion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Change in number of shares and votes in XVIVO Perfusion"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}